Mayo Clinic - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Mayo Clinic (Mayo) is a not-for-profit medical practice and medical research organization. It provides comprehensive medical facilities and programs related to patient care services, research and medical education. It offers specialized medical care with medical departments and centers in most of the major disease categories and health disorders. It conducts active human research studies and new human research studies approved by institutional review at its facilities. The organization also operates several colleges of medicine which offer various residency and fellowship programs. Its other major facilities include Mayo Arizona, Mayo Minnesota, and Mayo Clinic Health System, a network of clinics and hospitals in several states. Mayo is headquartered in Jacksonville, Florida, the US.

Mayo Clinic - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 6
List of Figures 7
Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 8
Mayo Clinic, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 9
Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 10
Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 11
Mayo Clinic, Medical Devices Deals, 2012 to YTD 2018 12
Mayo Clinic, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 13
Mayo Clinic, Pharmaceuticals & Healthcare, Deal Details 19
Venture Financing 19
Helix Opco Raises USD200 Million in Series B Financing 19
Unity Biotech Raises Additional USD35 Million in Series B Financing 21
Qrativ Raises USD8.3 Million in Series A Financing 23
Evelo Biosciences Raises USD50 Million in Series B Financing 24
DayTwo Secures USD12 Million in Series A Funding 26
DayTwo Raises USD12 Million in Series A Financing 27
UNITY Biotech Raises USD116 Million in Series B Financing 28
Second Genome Raises USD42.6 Million in Series B Financing 30
Unity Biotechnology Raises Funds in Venture Financing 32
AssureRx Health Raises Additional USD15 Million in Series D Financing 33
AssureRx Health Raises USD30 Million in Venture Financing Round 34
Chrono Therapeutics Raises USD32 Million in Series A Venture Financing 36
Seres Health Raises USD10 Million in Series B Financing 38
AssureRx Health Raises USD7 Million in Venture Financing 40
OxThera Raises US$10.7 Million In Venture Financing 42
Omnis Pharma Raises Funds in Seed Financing 43
AssureRx Health Raises US$12.5 Million In Series C Financing 44
Partnerships 46
Seven Hospitals and Three Philanthropic Foundations Form Civica RX 46
SkylineDx Enters into Co-Development Agreement with Mayo Clinic 48
Sphingotec Enters into Collaboration Agreement with Mayo Clinic 49
Mayo Clinic and nference Form Joint Venture 50
Baxter International and Mayo Clinic Enter into Research Agreement 51
Evelo Biosciences Enters into Research Agreement with Mayo Clinic 52
EnBiotix Partners with Mayo Clinic 53
Seres Therapeutics Enters into Research Agreement with Mayo Clinic 54
Inovio Pharma Partners with National Cancer Institute and Mayo Clinic 55
GE Ventures Forms Joint Venture with Mayo Clinic 56
Morphotek Enters into Agreement with Mayo Clinic 57
Mayo Clinic Forms Joint Venture with Hillhouse Capital 58
Second Genome Enters into Co-Development Agreement with Mayo Clinic Center for Individualized Medicine 59
Mayo Clinic Forms Joint Venture with Delos Living 60
Enterome Enters into Co-Development Agreement with Mayo Clinic 61
Seres Health Enters into Research Agreement with Mayo Clinic 62
Mayo Clinic Enters Into Co-Development Agreement With Banner Health For Diagnostic Tests 63
Mayo Clinic Forms Joint Venture With Cancer Genetics 64
Mayo Clinic Enters Into Research Agreement With Sanford-Burnham Medical Research Institute 66
Silicon Valley Biosystems Enters Into Agreement With Mayo Clinic For Genome Diagnostics 67
Optum Enters Into Joint Venture Agreement With Mayo Clinic 68
Mayo Clinic Enters Into Joint Venture With Select Medical To Form Allevant Solutions 69
Licensing Agreements 70
Elysium Health Enters into Licensing Agreement with Mayo Clinic and Harvard University 70
Imugene Enters into Licensing Agreement with Ohio State University Wexner Medical Center and Mayo Clinic 71
Evelo Biosciences Enters into Licensing Agreement with Mayo Foundation for Medical Education and Research 72
Mayo Clinic Enters into Licensing Agreement with ID Pharma 74
TapImmune Exercises Option for Licensing Agreement with Mayo Clinic 75
Omnis Pharma Enters into Licensing Agreement with Mayo Clinic Ventures 76
TapImmune Exercises Option for Licensing Agreement with Mayo Clinic for HER2/neu Vaccine Technology 77
Seres Therapeutics Enters into Licensing Agreement with Mayo Foundation for Medical Education and Research 78
PsychoGenics Enters Into Licensing Agreement With Mayo Clinic And TET Systems For rTg4510 Tauopathy Mouse Model 79
WuXi Pharma Enters Into Licensing Agreement With Mayo Clinic Center for Individualized Medicine 80
Nexus CMF Enters Into Licensing Agreement With Mayo Clinic For Prosthesis Technology 81
Zumbro Discovery Enters into Licensing Agreement with Mayo Clinic 82
Acquisition 83
Mayo Clinic Acquires Dartmouth-Hitchcock Medical Center 83
Mayo Clinic Health System Completes Acquisition Of Fairview Red Wing 84
Mayo Clinic - Key Competitors 85
Mayo Clinic - Key Employees 86
Mayo Clinic - Locations And Subsidiaries 87
Head Office 87
Other Locations & Subsidiaries 87
Joint Venture 89
Recent Developments 90
Strategy And Business Planning 90
Sep 06, 2018: Not-for-profit generic drug company officially established, attracts interest of more than 120 health organizations 90
Sep 06, 2018: Mayo Clinic joins hospitals to launch a not-for-profit generic drug company 91
May 10, 2018: Vyriad to Build State-of-the-Art Facility for Manufacturing Oncolytic Virus Anti-Cancer Vaccines in Rochester, Minn. 92
Jul 14, 2017: Mayo Clinic, nference Launch a Startup to Discover, Develop Treatments for Diseases with Unmet Medical Need 93
Corporate Communications 95
Nov 09, 2018: Mayo Clinic elects Kent Thielen, M.D., CEO of its Florida operations; Mayos board of trustees also names two new members 95
Legal and Regulatory 98
Jun 25, 2018: Court Agrees with Atrium Health, Rejecting Attempt by Mednax to Disrupt Transition to New Anesthesia Partner 98
Jan 09, 2018: FDA clears way for Mayo Clinic to accelerate production of stem cells for clinical trials through automation 99
Government and Public Interest 100
Oct 10, 2018: Mayo Clinic researchers identify gene types driving racial disparities in myeloma 100
Oct 10, 2018: Columbia scientist Anthony Fitzpatrick and collaborators awarded $7.8M to identify new targets against brain disease 101
Oct 10, 2018: Mayo Clinic researchers study immunity-boosting vaccine to target aggressive form of breast cancer 102
Oct 08, 2018: Mayo Clinic Researchers Question Benefits of Long Term Oxygen Therapy in COPD 103
Oct 02, 2018: Liver transplant, weight-loss surgery combination benefits obese patients in long term 104
Oct 01, 2018: NIH, DoD to develop Limb Loss and Preservation Registry 105
Sep 28, 2018: Mayo Clinic researchers receive specialized program of Research Excellence grant for liver and biliary cancer from the National Cancer Institute 106
Sep 20, 2018: Opioid controlled substance agreements safely reduce health care visits Mayo study finds 107
Sep 18, 2018: New COPD guidelines from international panel provide updated recommendations 108
Aug 01, 2018: Number of opioid prescriptions remains unchanged, Mayo Clinic research finds 109
Jul 30, 2018: FSU faculty awarded $226M in research dollars 111
Jul 25, 2018: Drug for Alzheimers disease shows early promise 112
Jun 21, 2018: Unusually High Levels of Herpesviruses Found in the Alzheimers Disease Brain, Mount Sinai Researchers Report 113
Jun 19, 2018: Mayo Clinic discovers gene mutations linked to pancreatic cancer, calls for expanded testing 115
May 31, 2018: Hyundai Hope On Wheels Announces Four Quantum Award Grant Recipients To Receive A Total Funding Of $5.5 Million Towards Pediatric Cancer Research 116
May 23, 2018: Foundation for Anesthesia Education and Research Awards $1.4 million in Grants 118
May 18, 2018: Biotin supplements caused misleading test results, almost led to unnecessary procedure 121
May 01, 2018: Mayo Clinic joins NIH in launching All of Us Research Program 122
Feb 21, 2018: Early results from clinical trials not all theyre cracked up to be, shows new research 123
Jan 25, 2018: Research test identifies BRCA2 gene mutations that lead to breast, ovarian cancers 124
Jan 17, 2018: Patients with blood cancer precursor at risk of developing cancer even after 30 years 125
Jan 03, 2018: Research finds hysterectomy alone associated with increased long-term health risks 126
Dec 11, 2017: USC, Harvard-affiliated hospitals & Mayo Clinic team up to streamline Alzheimers research 127
Nov 01, 2017: New Study Links Severe Hot Flashes With Greater Risk of Obstructive Sleep Apnea 129
Oct 24, 2017: Proton therapy may be better option for elderly patients with esophageal cancer 130
Sep 25, 2017: Halving radiation therapy for HPV-related throat cancer offers fewer side effects, similar outcomes 131
Sep 18, 2017: Scientists Discover Novel Mechanism Underlying ALS and Related Dementia 132
Aug 29, 2017: Study finds hormone therapy improves sleep quality for recently menopausal women 133
Aug 25, 2017: Study identifies genes linked to better immune response to flu vaccine 134
May 02, 2017: Mayo Clinic researchers develop new tumor-shrinking nanoparticle to fight cancer, prevent recurrence 135
Jan 09, 2017: Mayo Clinic researchers identify new potential treatment for cancer metastasis 136
Product News 137
Nov 20, 2017: New oral anticoagulant drugs associated with lower kidney risks, Mayo Clinic research shows 137
Nov 01, 2017: Mayo Clinic researchers find genetic pathways to individualized treatment for advanced prostate cancer 139
10/04/2018: Mayo researchers identify potential new treatment for subset of women with triple-negative breast cancer 140
Jul 09, 2018: Senolytics Improve Health, Extend life: Preclinical research findings 141
Jul 02, 2018: Mayo researchers find off/on switch for DNA repair protein 142
May 16, 2018: Mayo study identifies new potential treatment option for triple negative breast cancer 143
May 16, 2018: Mayo discovery means individualized ovarian, brain cancer therapies 144
May 03, 2017: Mayo Clinic-invented technologies show brain tumor firmness, adhesion before surgery 145
Mar 08, 2018: Mayo Clinics clinical trial matching project sees higher enrollment in breast cancer trials through use of artificial intelligence 146
Other Significant Developments 147
Oct 23, 2018: Mayo Clinic national health checkup: most Americans would choose an alternative to opioids following surgery 147
Oct 09, 2018: Mayo Clinic first to perform CAR T-cell therapy in NE Florida 149
Sep 27, 2018: ImmunogenX completes CypCel trial for celiac disease 150
Sep 13, 2018: Viruses show new promise in treating cancer 151
Aug 15, 2018: Healthcare Innovators professional society reaches member goal of 33 top industry executives for nationwide council 153
Jun 15, 2018: Mayo Clinic brings national Smithsonian exhibit to Rochester Art Center 154
Apr 03, 2018: Mayo Clinic to coordinate new effort to expand medical research, expert care for Lewy body dementia patients 155
Appendix 156
Methodology 156
About GlobalData 156
Contact Us 156
Disclaimer 156

List Of Tables


Mayo Clinic, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 8
Mayo Clinic, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 9
Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 10
Mayo Clinic, Deals By Therapy Area, 2012 to YTD 2018 11
Mayo Clinic, Medical Devices Deals, 2012 to YTD 2018 12
Mayo Clinic, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 13
Helix Opco Raises USD200 Million in Series B Financing 19
Unity Biotech Raises Additional USD35 Million in Series B Financing 21
Qrativ Raises USD8.3 Million in Series A Financing 23
Evelo Biosciences Raises USD50 Million in Series B Financing 24
DayTwo Secures USD12 Million in Series A Funding 26
DayTwo Raises USD12 Million in Series A Financing 27
UNITY Biotech Raises USD116 Million in Series B Financing 28
Second Genome Raises USD42.6 Million in Series B Financing 30
Unity Biotechnology Raises Funds in Venture Financing 32
AssureRx Health Raises Additional USD15 Million in Series D Financing 33
AssureRx Health Raises USD30 Million in Venture Financing Round 34
Chrono Therapeutics Raises USD32 Million in Series A Venture Financing 36
Seres Health Raises USD10 Million in Series B Financing 38
AssureRx Health Raises USD7 Million in Venture Financing 40
OxThera Raises US$10.7 Million In Venture Financing 42
Omnis Pharma Raises Funds in Seed Financing 43
AssureRx Health Raises US$12.5 Million In Series C Financing 44
Seven Hospitals and Three Philanthropic Foundations Form Civica RX 46
SkylineDx Enters into Co-Development Agreement with Mayo Clinic 48
Sphingotec Enters into Collaboration Agreement with Mayo Clinic 49
Mayo Clinic and nference Form Joint Venture 50
Baxter International and Mayo Clinic Enter into Research Agreement 51
Evelo Biosciences Enters into Research Agreement with Mayo Clinic 52
EnBiotix Partners with Mayo Clinic 53
Seres Therapeutics Enters into Research Agreement with Mayo Clinic 54
Inovio Pharma Partners with National Cancer Institute and Mayo Clinic 55
GE Ventures Forms Joint Venture with Mayo Clinic 56
Morphotek Enters into Agreement with Mayo Clinic 57
Mayo Clinic Forms Joint Venture with Hillhouse Capital 58
Second Genome Enters into Co-Development Agreement with Mayo Clinic Center for Individualized Medicine 59
Mayo Clinic Forms Joint Venture with Delos Living 60
Enterome Enters into Co-Development Agreement with Mayo Clinic 61
Seres Health Enters into Research Agreement with Mayo Clinic 62
Mayo Clinic Enters Into Co-Development Agreement With Banner Health For Diagnostic Tests 63
Mayo Clinic Forms Joint Venture With Cancer Genetics 64
Mayo Clinic Enters Into Research Agreement With Sanford-Burnham Medical Research Institute 66
Silicon Valley Biosystems Enters Into Agreement With Mayo Clinic For Genome Diagnostics 67
Optum Enters Into Joint Venture Agreement With Mayo Clinic 68
Mayo Clinic Enters Into Joint Venture With Select Medical To Form Allevant Solutions 69
Elysium Health Enters into Licensing Agreement with Mayo Clinic and Harvard University 70
Imugene Enters into Licensing Agreement with Ohio State University Wexner Medical Center and Mayo Clinic 71
Evelo Biosciences Enters into Licensing Agreement with Mayo Foundation for Medical Education and Research 72
Mayo Clinic Enters into Licensing Agreement with ID Pharma 74
TapImmune Exercises Option for Licensing Agreement with Mayo Clinic 75
Omnis Pharma Enters into Licensing Agreement with Mayo Clinic Ventures 76
TapImmune Exercises Option for Licensing Agreement with Mayo Clinic for HER2/neu Vaccine Technology 77
Seres Therapeutics Enters into Licensing Agreement with Mayo Foundation for Medical Education and Research 78
PsychoGenics Enters Into Licensing Agreement With Mayo Clinic And TET Systems For rTg4510 Tauopathy Mouse Model 79
WuXi Pharma Enters Into Licensing Agreement With Mayo Clinic Center for Individualized Medicine 80
Nexus CMF Enters Into Licensing Agreement With Mayo Clinic For Prosthesis Technology 81
Zumbro Discovery Enters into Licensing Agreement with Mayo Clinic 82
Mayo Clinic Acquires Dartmouth-Hitchcock Medical Center 83
Mayo Clinic Health System Completes Acquisition Of Fairview Red Wing 84
Mayo Clinic, Key Competitors 85
Mayo Clinic, Key Employees 86
Mayo Clinic, Other Locations 87
Mayo Clinic, Subsidiaries 87
Mayo Clinic, Joint Venture 89

List Of Figures


Mayo Clinic, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 8
Mayo Clinic, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 9
Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 10
Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 11
Mayo Clinic, Medical Devices Deals, 2012 to YTD 2018 12

Mayo Clinic - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Mayo Clinic (Mayo) is a not-for-profit medical practice and medical research organization. It provides comprehensive medical facilities and programs related to patient care services, research and medical education. It offers

USD 250 View Report

Mayo Clinic - Mergers and Acquisitions (MandA), Partnerships and Alliances and Investment Report

Mayo Clinic - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportThe Mayo Clinic Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports

USD 350 View Report

Mayo Clinic - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Mayo Clinic (Mayo) is a not-for-profit medical practice and medical research organization. It provides comprehensive medical facilities and programs related to patient care services, research and medical education. It offers

USD 250 View Report

Mayo Clinic - Mergers and Acquisitions (MandA), Partnerships and Alliances and Investment Report

Mayo Clinic - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportThe Mayo Clinic Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports

USD 350 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available